Sumita Ray, J.D. is the Chief Legal & Compliance Officer and Corporate Secretary at Cue Biopharma. She has been in the biotech industry for over 25 years and has held positions as Chief Legal & Compliance Officer for over a decade at various publicly traded companies. She has operated at various companies as an executive leader supporting companies throughout their lifecycles, from inception and pre-clinical studies to commercialization and M&A. Ms. Ray has experience across a wide range of therapeutic areas including immunology and has collaborated with teams to launch and support blockbuster therapies including CRESTOR®, TYSABRI®, IMBRUVICA®, and AVASTIN®.
Prior to joining Cue, she served as Chief Legal Officer and Corporate Secretary at AZEO BIO, Inc., a privately held company. Before that, she was Chief Legal, Compliance & Administrative Officer and Corporate Secretary at Vaxxinity (Nasdaq: VAXX), a formerly public biotechnology company. Prior to that, Ms. Ray held the position of Chief Legal, Compliance & Administrative Officer and Corporate Secretary at the public biotechnology companies of Instil Bio, Inc. (Nasdaq: TIL) and Calithera BioSciences, Inc. (Nasdaq: CALA). Earlier in her career, Ms. Ray held senior and executive leadership roles of increasing responsibility at Astrazeneca, Genentech, Elan Pharmaceuticals and Pharmacyclics.
Ms. Ray began her career in private practice as a pharmaceutical and products liability litigator at the law firm of Montgomery, McCracken, Walker & Rhoads LLP. She currently serves on the Board of Directors of Biomea Fusion, Inc. (Nasdaq: BMEA), to which she was appointed in July 2021. Ms. Ray holds a Juris Doctor from Temple University School of Law and a B.S. in Microbiology with a minor in Chemistry from the University of Arizona. She is admitted to practice law in Pennsylvania and New Jersey.
What is Sumita Ray's net worth?
The estimated net worth of Sumita Ray is at least $3.17 million as of August 13th, 2026. Ms. Ray owns 118,545 shares of Cue Biopharma stock worth more than $3,166,455 as of August 25th. This net worth evaluation does not reflect any other investments that Ms. Ray may own. Learn More about Sumita Ray's net worth.
How do I contact Sumita Ray?
Has Sumita Ray been buying or selling shares of Cue Biopharma?
In the last ninety days, Sumita Ray has sold $265,664.61 in Cue Biopharma stock. Most recently, Sumita Ray sold 8,829 shares of the business's stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $30.09, for a transaction totalling $265,664.61. Following the completion of the sale, the insider now directly owns 118,545 shares of the company's stock, valued at $3,567,019.05. Learn More on Sumita Ray's trading history.
Who are Cue Biopharma's active insiders?
Are insiders buying or selling shares of Cue Biopharma?
In the last year, insiders at the sold shares 4 times. They sold a total of 72,715 shares worth more than $2,041,555.09. The most recent insider tranaction occured on August, 13th when CEO Shao-Lee Lin sold 18,258 shares worth more than $522,543.96. Insiders at Cue Biopharma own 14.6% of the company.
Learn More about insider trades at Cue Biopharma. Information on this page was last updated on 8/13/2026.
